Oct 2 -
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
It was published on October 2, 2026 on Semasocial.
It was written by CNBC on Semasocial.
News Source
CNBC is the world leader in business news and real-time financial market coverage. Find fast, actionable information.
Comment